Winn RJ - Search Results

1

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.

Moore DF Jr, Pazdur R, Abbruzzese JL, Ajani JA, Dubovsky DW, Wade JL 3rd, Belt RJ, Mangold C, Bready B, Winn RJ. Moore DF Jr, et al. Among authors: winn rj. Ann Oncol. 1994 Mar;5(3):286-7. doi: 10.1093/oxfordjournals.annonc.a058810. Ann Oncol. 1994. PMID: 8186177 Free article. Clinical Trial.

2

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B. Pazdur R, et al. Among authors: winn r. Cancer. 1992 Oct 15;70(8):2073-6. doi: 10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a. Cancer. 1992. PMID: 1394037 Clinical Trial.

3

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

4

A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.

Pazdur R, Ajani JA, Winn R, Bearden J, Belt RJ, Pilat S, Hallinan R, Levin B. Pazdur R, et al. Among authors: winn r. Cancer. 1992 Feb 15;69(4):878-82. doi: 10.1002/1097-0142(19920215)69:4<878::aid-cncr2820690407>3.0.co;2-0. Cancer. 1992. PMID: 1735078 Clinical Trial.

5

Phase II study of amonafide in advanced pancreatic adenocarcinoma.

Linke K, Pazdur R, Abbruzzese JL, Ajani JA, Winn R, Bradof JE, Daugherty K, Levin B. Linke K, et al. Invest New Drugs. 1991 Nov;9(4):353-6. doi: 10.1007/BF00183580. Invest New Drugs. 1991. PMID: 1804812 Clinical Trial.

6

Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.

Pazdur R, Ajani JA, Patt YZ, Winn R, Jackson D, Shepard B, DuBrow R, Campos L, Quaraishi M, Faintuch J, et al. Pazdur R, et al. J Clin Oncol. 1990 Dec;8(12):2027-31. doi: 10.1200/JCO.1990.8.12.2027. J Clin Oncol. 1990. PMID: 2230894 Clinical Trial.

7

Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma.

Pazdur R, Diaz-Canton E, Ballard WP, Bradof JE, Graham S, Arbuck SG, Abbruzzese JL, Winn R. Pazdur R, et al. J Clin Oncol. 1997 Aug;15(8):2905-9. doi: 10.1200/JCO.1997.15.8.2905. J Clin Oncol. 1997. PMID: 9256134 Clinical Trial.

8

Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.

Royce ME, McGarry W, Bready B, Dakhil SR, Belt RJ, Goodwin JW, Gray R, Hoff PM, Winn R, Pazdur R. Royce ME, et al. Among authors: winn r. J Clin Oncol. 1999 Oct;17(10):3276-82. doi: 10.1200/JCO.1999.17.10.3276. J Clin Oncol. 1999. PMID: 10506630 Clinical Trial.

9

Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.

Ravandi F, Rytting ME, Osmon C, Braud EL, Roach RW, Edwards K, Winn R, Abbruzzese JL, Pazdur R. Ravandi F, et al. Anticancer Drugs. 1999 Jul;10(6):519-24. doi: 10.1097/00001813-199907000-00002. Anticancer Drugs. 1999. PMID: 10885898 Clinical Trial.

10

Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Wiseman C, Lenado-Lee MA, Patt YZ, Krakoff IH. Ajani JA, et al. Among authors: winn rj. Invest New Drugs. 1991 Aug;9(3):257-9. doi: 10.1007/BF00176979. Invest New Drugs. 1991. PMID: 1783525 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page